Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
A Stepwise Approach to Donor Preparation and Insertion Increases Safety and Outcome of Descemet Membrane Endothelial Keratoplasty
- F. Kruse, K. Laaser, +4 authors B. Bachmann
- Medicine
- Cornea
- 1 May 2011
Purpose: Lamellar techniques for selective replacement of diseased corneal structures have recently been improved. Descemet membrane endothelial keratoplasty (DMEK) allows the sole replacement of the… Expand
Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage.
- L. Heindl, Stephan Riss, B. Bachmann, K. Laaser, F. Kruse, C. Cursiefen
- Medicine
- Ophthalmology
- 1 February 2011
PURPOSE
To evaluate the feasibility of using a single donor cornea for 2 recipients by combining deep anterior lamellar keratoplasty (DALK) and Descemet's membrane endothelial keratoplasty (DMEK)… Expand
Corneal confocal microscopy detects small fiber damage in chronic inflammatory demyelinating polyneuropathy (CIDP)
- C. Schneider, F. Bucher, C. Cursiefen, G. Fink, L. Heindl, H. Lehmann
- Medicine
- Journal of the peripheral nervous system : JPNS
- 1 December 2014
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune‐mediated peripheral neuropathy with multifocal involvement. Reliable biomarkers for diagnosis, disease progression, and… Expand
Optimizing descemet membrane endothelial keratoplasty using intraoperative optical coherence tomography.
- P. Steven, C. Le Blanc, +7 authors C. Cursiefen
- Medicine
- JAMA ophthalmology
- 1 September 2013
IMPORTANCE
Descemet membrane endothelial keratoplasty (DMEK) is a challenging procedure for the surgeon, particularly because of deficient visibility of the delicate tissue due to the natural en face… Expand
Split cornea transplantation for 2 recipients - review of the first 100 consecutive patients.
- L. Heindl, Stephan Riss, K. Laaser, B. Bachmann, F. Kruse, C. Cursiefen
- Medicine
- American journal of ophthalmology
- 1 October 2011
PURPOSE
To evaluate the feasibility of split cornea transplantation for 2 recipients by combining deep anterior lamellar keratoplasty (DALK) and Descemet membrane endothelial keratoplasty (DMEK).
… Expand
Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19)
- J. C. Luers, A. Rokohl, +6 authors L. Heindl
- Medicine
- Clinical infectious diseases : an official…
- 1 May 2020
Abstract Coronavirus-disease-2019 (COVID-19) caused by the severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) shows a rapid spread over-the-world. Given scarce resources, non-laboratory… Expand
Spectrum of Uveitis in A German Tertiary Center: Review of 474 Consecutive Patients
- R. Grajewski, A. Caramoy, +5 authors L. Heindl
- Medicine
- Ocular immunology and inflammation
- 4 July 2015
Abstract Purpose: To analyze the spectrum of uveitis at a German tertiary center. Patients and methods: A total of 474 consecutive patients with uveitis were classified according to the primary… Expand
Ophthalmological manifestations of Parry-Romberg syndrome.
- F. Bucher, J. Fricke, A. Neugebauer, C. Cursiefen, L. Heindl
- Medicine
- Survey of ophthalmology
- 1 November 2016
Parry-Romberg syndrome is a rare disease characterized by slowly progressive atrophy affecting facial subcutaneous tissues, including the underlying muscles and osteocartilaginous structures. Various… Expand
Microbubble Incision as a New Rescue Technique for Big-Bubble Deep Anterior Lamellar Keratoplasty With Failed Bubble Formation
- Stephan Riss, L. Heindl, B. Bachmann, F. Kruse, C. Cursiefen
- Materials Science, Medicine
- Cornea
- 1 February 2013
Purpose: To describe a new surgical technique allowing dissection down to Descemet membrane in big-bubble deep anterior lamellar keratoplasty (DALK) with failed big-bubble formation (the “microbubble… Expand
Aktuelle Diagnostik und Therapieempfehlungen beim Basalzellkarzinom am Auge
- V. Kakkassery, K. Loeffler, +5 authors L. Heindl
- Medicine
- Der Ophthalmologe
- 1 March 2017
ZusammenfassungBei der Behandlung des Basalzellkarzinoms haben sich in neuester Zeit mit erfolgten bzw. anstehenden Zulassungen von Chemotherapeutika die Therapieoptionen erweitert. Ebenso sind zu… Expand